Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liver

Int J Parasitol. 1993 May;23(3):427-9. doi: 10.1016/0020-7519(93)90023-r.

Abstract

The parasiticidal properties of doxorubicin against the metacestode of Echinococcus multilocularis were investigated after binding of that drug to polyisohexylcyanoacrylate nanoparticles, a colloidal biodegradable drug carrier. A reduction of the hepatic parasite development and a reduced viability of the metacestode were observed in mice injected with 5 mg kg-1 body weight-1, but 7.5 mg kg-1 body weight-1 did not appear more efficient. Free doxorubicin or unbound nanoparticles had no antiparasitic activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colloids
  • Cyanoacrylates*
  • Doxorubicin / administration & dosage
  • Doxorubicin / therapeutic use*
  • Drug Carriers
  • Echinococcosis, Hepatic / drug therapy*
  • Female
  • Mice
  • Mice, Inbred AKR

Substances

  • Colloids
  • Cyanoacrylates
  • Drug Carriers
  • poly(hexyl-2-cyanoacrylate)
  • Doxorubicin